At this time, there are no Federal Drug Administration (FDA) approved vaccines to prevent COVID-19 or other coronaviruses.
The U.S. Food & Drug Administration (FDA) is working with vaccine developers and other researchers and manufacturers to help with the development and availability of medical products such as vaccines, antibodies and drugs to prevent COVID-19.
The significant impact of COVID-19 has led to unprecedented, worldwide collaboration amongst scientists, health and government officials and manufacturers. On May 15, 2020, the Trump Administration announced a national program to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, treatments and medical countermeasures, called Operation Warp Speed. The program will bring together leaders from the U.S. Department of Health and Human Services, the Centers for Disease Control and Prevention, the Food & Drug Administration, the National Institutes of Health, and the Department of Defense, as well as private firms. Experts from these organizations will oversee the process and protocols for COVID-19 vaccine development, manufacturing and distribution, with the goal of having substantial quantities of a safe and effective vaccine available in the U.S. by January 2021.